Hôtel-Dieu de Québec
11 Côte du Palais
Québec, QC
Canada G1R 2J6
Dernières nouvelles
Information non disponible
- Anderson, AudreyEmployé
- Becerra Perez, Maria MargaritaEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67526Maria-Margarita.Becerra-Perez@crchudequebec.ulaval.ca
1401, 18e rue
G3.453
Québec, QC
Canada G1J 1Z4 - Bergeron, Karol-AnneEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67315karol-anne.bergeron@crchudequebec.ulaval.ca
1401, 18e rue
G2.460
Québec, QC
Canada G1J 1Z4 - Bordeleau, SophieEmployésophie.bordeleau@crchudequebec.ulaval.ca
- Bouchard, AnnickEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67314annick.bouchard@crchudequebec.ulaval.ca
1401, 18e rue
G2.460
Québec, QC
Canada G1J 1Z4 - Bradley, MélanieEmployéHôpital Saint-Sacrement
1050, chemin Sainte-Foy
Québec, Québec
Canada G1S 4L8Hôpital de l'Enfant-Jésus+1 418-525-4444, poste 67525+1 418-691-5065melanie.bradley@chudequebec.camelanie.bradley@crchudequebec.ulaval.ca
1401, 18e rue
G3.453
Québec, QC
Canada G1J 1Z4 - Brochu, Marie-PierreEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67512marie-pierre.brochu@chudequebec.camarie-pierre.brochu@crchudequebec.ulaval.ca
1401, 18e rue
G2.460
Québec, QC
Canada G1J 1Z4 - Cantin, WilliamEmployéHôpital de l'Enfant-Jésuswilliam.cantin@crchudequebec.ulaval.ca
1401, 18e rue
G3.514
Québec, QC
Canada G1J 1Z4 - Chabot, PatriciaEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67310patricia.chabot@chudequebec.capatricia.chabot@crchudequebec.ulaval.ca
1401, 18e rue
G2.457
Québec, QC
Canada G1J 1Z4 - Diamant-Léonard, NoémieEmployénoemie.diamant-leonard@crchudequebec.ulaval.ca
- Ezzine, HoudaEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67542houda.ezzine@chudequebec.ca
1401, 18e rue
G3.514
Québec, QC
Canada G1J 1Z4 - Gingras, MaryseEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67322maryse.gingras@chudequebec.camaryse.gingras@crchudequebec.ulaval.ca
1401, 18e rue
G2.468
Québec, QC
Canada G1J 1Z4 - Gyejacquot, SophieEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 15181sophie.gyejacquot@crchudequebec.ulaval.ca
1401, 18e rue
G3.457
Québec, QC
Canada G1J 1Z4 - Lavoie, SandyEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67309+1 418-691-2920sandy.lavoie.1@ulaval.caSandy.Lavoie@crchudequebec.ulaval.ca
1401, 18e rue
G2.457
Québec, QC
Canada G1J 1Z4 - Nadeau, BiancaEmployéL'Hôtel-Dieu de Québec+1 418-525-4444bianca.nadeau@crchudequebec.ulaval.ca
9 rue McMahon
Québec, QC
Canada G1R 3S3 - Ndayizigiye, AliceEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67308alice.ndayizigiye.1@ulaval.caAlice.Ndayizigiye@crchudequebec.ulaval.ca
1401, 18e rue
G2.457
Québec, QC
Canada G1J 1Z4 - Rochette, GenevièveEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67540genevieve.rochette@chudequebec.ca
1401, 18e rue
C2633
Québec, QC
Canada G1J 1Z4 - St-Pierre, DominiqueEmployéHôpital Saint-Sacrement
1050, Chemin Ste-Foy
Québec, Québec
Canada G1S 4L8Hôpital de l'Enfant-Jésus+1 418-525-4444, poste 67524dspierre@crchudequebec.ulaval.ca
1401, 18e rue
G3.453
Québec, QC
Canada G1J 1Z4
Association between physical activity and the time course of cancer recurrence in stage III colon cancer
Article de revueBr J Sports Med, 2023.
Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer
Article de revueJAMA Oncol, 9 (3), 2023.
CAR T-Cells for the Treatment of Refractory or Relapsed Large B-Cell Lymphoma: A Single-Center Retrospective Canadian Study
Article de revueClin Lymphoma Myeloma Leuk, 23 (3), 2023.
Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702
Article de revueJ Clin Oncol, 41 (5), 2023.
UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways
Article de revueCancer Lett, 553 , 2023.
Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)
Article de revueJ Clin Oncol, 41 (2), 2023.
The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma
Article de revueNat Commun, 13 (1), 2022.
Stress-buffering effect of social support on immunity and infectious risk during chemotherapy for breast cancer
Article de revueBrain Behav Immun Health, 10 , 2021.
Standard-Dose Pembrolizumab Plus Alternate-Dose Ipilimumab in Advanced Melanoma: KEYNOTE-029 Cohort 1C, a Phase 2 Randomized Study of Two Dosing Schedules
Article de revueClin Cancer Res, 27 (19), 2021.
Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer
Article de revueClin Transl Med, 11 (4), 2021.
Projets terminés récemment
- Multi-pathway cholesterol depletion on top of FOLFIRINOX in newly diagnosed metastatic pancreatic adenocarcinoma: a feasibility and proof-of-concept study, du 2019-10-01 au 2021-09-30